Loading...
Please wait, while we are loading the content...
Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival? A systematic review and meta-analysis of randomized controlled trials.
| Content Provider | Europe PMC |
|---|---|
| Author | Uson Junior, P.L.S. Dias e Silva, D. de Castro, N.M. da Silva Victor, E. Rother, E.T. Araújo, S.E.A. Borad, M.J. Moura, F. |
| Copyright Year | 2022 |
| Journal | ESMO Open |
| Volume Number | 8 |
| PubMed Central reference number | PMC10024142 |
| Issue Number | 1 |
| PubMed reference number | 36638709 |
| e-ISSN | 20597029 |
| DOI | 10.1016/j.esmoop.2022.100771 |
| Language | English |
| Publisher | BMJ |
| Publisher Date | 2023-01-11 |
| Access Restriction | Open |
| Rights License | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). © 2022 The Authors |
| Subject Keyword | resectable pancreatic cancer chemotherapy gemcitabine neoadjuvant treatment FOLFIRINOX overall survival |
| Content Type | Text |
| Resource Type | Article |
| Subject | Oncology Cancer Research |